Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

794 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Teriflunomide slows BVL in relapsing MS: A reanalysis of the TEMSO MRI data set using SIENA.
Radue EW, Sprenger T, Gaetano L, Mueller-Lenke N, Cavalier S, Thangavelu K, Panzara MA, Donaldson JE, Woodward FM, Wuerfel J, Wolinsky JS, Kappos L. Radue EW, et al. Among authors: kappos l. Neurol Neuroimmunol Neuroinflamm. 2017 Aug 9;4(5):e390. doi: 10.1212/NXI.0000000000000390. eCollection 2017 Sep. Neurol Neuroimmunol Neuroinflamm. 2017. PMID: 28828394 Free PMC article.
A randomized, double-blind, dose-comparison study of weekly interferon beta-1a in relapsing MS.
Clanet M, Radue EW, Kappos L, Hartung HP, Hohlfeld R, Sandberg-Wollheim M, Kooijmans-Coutinho MF, Tsao EC, Sandrock AW; European IFNbeta-1a (Avonex) Dose-Comparison Study Investigators. Clanet M, et al. Among authors: kappos l. Neurology. 2002 Nov 26;59(10):1507-17. doi: 10.1212/01.wnl.0000032256.35561.d6. Neurology. 2002. PMID: 12451189 Clinical Trial.
Interferon-beta antibodies: implications for the treatment of MS.
Wolinsky JS, Toyka KV, Kappos L, Grossberg SE. Wolinsky JS, et al. Among authors: kappos l. Lancet Neurol. 2003 Sep;2(9):528. doi: 10.1016/s1474-4422(03)00499-x. Lancet Neurol. 2003. PMID: 12941572 Review. No abstract available.
Rate of brain atrophy in relapsing MS decreases during treatment with IFNbeta-1a.
Hardmeier M, Wagenpfeil S, Freitag P, Fisher E, Rudick RA, Kooijmans M, Clanet M, Radue EW, Kappos L; European IFN-1a in Relapsing MS Dose Comparison Trial Study Group. Hardmeier M, et al. Among authors: kappos l. Neurology. 2005 Jan 25;64(2):236-40. doi: 10.1212/01.WNL.0000149516.30155.B8. Neurology. 2005. PMID: 15668419 Clinical Trial.
794 results